Please login to the form below

Not currently logged in
Email:
Password:

OncoMed Pharmaceuticals

This page shows the latest OncoMed Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

Sanofi enters vaccines partnership with Sutro

Sanofi enters vaccines partnership with Sutro

Dr Jeremy Bender joined from Allos as chief business officer, while Dr Aaron Sato joined from OncoMed Pharmaceuticals as VP, research.

Latest news

  • Diabetes favoured

    575. Orexo/Ortho-McNeil-Janssen. Small molecules for COPD and asthma. Discovery. 574. Oncomed Pharmaceuticals/Bayer Schering. ... ElexoPharm/Merck &Co. Aldosterone synthase targets for cardiovascular disease. Discovery. 42. Adeona Pharmaceuticals/Meda.

  • GSK to develop cancer drugs with OncoMed

    UK pharmaceutical company GlaxoSmithKline (GSK) and US-based biotech OncoMed Pharmaceuticals have partnered to discover, develop and market antibody therapeutics to target cancer stem cells. ... GSK also has option to license four OncoMed product

More from news
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • OncoMed’s CMO steps down OncoMed’s CMO steps down

    Dr Jakob Dupont to leave the clinical-stage company. OncoMed Pharmaceuticals' Dr Jakob Dupont has resigned as senior vice president and chief medical officer, and is due to step down from ... Paul Hastings, OncoMed's chairman and chief executive officer,

  • Astellas bolsters oncology clinical development leadership Astellas bolsters oncology clinical development leadership

    He brings senior leadership experience in clinical development, compliance and licensing fromOncoMed Pharmaceuticals and PDL BioPharma, as well as academic experience from the University of North Carolina's Chapel Hill School

  • Sutro Biopharma hires chief business officer and VP research Sutro Biopharma hires chief business officer and VP research

    He was also heavily involved in the acquisition of Allos by Spectrum Pharmaceuticals. ... Dr Sato joins Sutro from OncoMed Pharmaceuticals, where he served as senior director of antibody engineering.

More from appointments
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

The new UK government-pharma industry pricing agreement – welcome news, but there are lessons to be learnt
...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again – in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics